With a revenue increase of 2.69% in the second quarter 2026, year on year to cumulative value of $1,555 million, Lantheus Holdings Inc 's revenue per employee grew on a trailing twelve months basis to $ 1,303,724, this marks a new company high. Within the Healthcare sector Employees of 62 other companies have achieved higher revenue per employee. While Lantheus Holdings Inc 's total ranking has deteriorated compared to the previous quarter from 489 to 687. Lantheus Holdings Inc has 1,193 employees.
In a pivotal moment for prostate cancer therapy, Lantheus Holdings, Inc. has presented compelling findings from the Phase 3 SPLASH trial at the 2024 European Society for Medical Oncology (ESMO) Congress. This landmark trial focused on men with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC). By achieving its primary endpoint of significant improvement in radiographic progression-free survival (rPFS), this study not only underscores the potential of novel radiopharmaceuticals but also signals a promising shift for patients grappling with this challenging malignancy. Trial OverviewThe SPLASH trial, designed as a global, randomized, double-blind study, evaluated the efficacy of Lantheus PSMA-targeted therapy compared to standard of care in men with progressive mCRPC. The study enrolled a diverse cohort, ensuring findings could be generalized across various populations. With the primary capturing rPFS a critical metric in oncology results demonstrated a noteworthy enhancement in survival without radiographic progression for patients receiving the PSMA-targeted intervention.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
